{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T16:19:50Z","timestamp":1792685990340,"version":"4.5.0"},"reference-count":95,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82300191"],"award-info":[{"award-number":["82300191"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82170115"],"award-info":[{"award-number":["82170115"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82525057"],"award-info":[{"award-number":["82525057"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011933","name":"Chongqing Science and Technology Foundation","doi-asserted-by":"publisher","award":["CSTB2024NSCQ-KJFZMSX0085"],"award-info":[{"award-number":["CSTB2024NSCQ-KJFZMSX0085"]}],"id":[{"id":"10.13039\/501100011933","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2024T171104"],"award-info":[{"award-number":["2024T171104"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019531","name":"Science Fund for Distinguished Young Scholars of Chongqing Municipality","doi-asserted-by":"publisher","award":["CSTB2022NSCQ-JQX0032"],"award-info":[{"award-number":["CSTB2022NSCQ-JQX0032"]}],"id":[{"id":"10.13039\/501100019531","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004374","name":"Chongqing Medical University","doi-asserted-by":"publisher","award":["cqmudstd202211"],"award-info":[{"award-number":["cqmudstd202211"]}],"id":[{"id":"10.13039\/501100004374","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Stem Cell"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.stem.2026.03.012","type":"journal-article","created":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T14:42:10Z","timestamp":1776955330000},"page":"800-819.e9","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["MMRN1-EGFR drives sialylglycan-Siglec immune evasion in AML leukemia stem cells"],"prefix":"10.1016","volume":"33","author":[{"given":"Meixi","family":"Peng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongxiu","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengyun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinrong","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lulu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaoqi","family":"Gui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingsong","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanni","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Mo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenqiong","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongjie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3896-5321","authenticated-orcid":false,"given":"Yu","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.stem.2026.03.012_bib1","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/s41591-018-0014-x","article-title":"Understanding the tumor immune microenvironment (TIME) for effective therapy","volume":"24","author":"Binnewies","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.stem.2026.03.012_bib2","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1182\/blood.V75.3.555.555","article-title":"Graft-versus-leukemia reactions after bone marrow transplantation","volume":"75","author":"Horowitz","year":"1990","journal-title":"Blood"},{"key":"10.1016\/j.stem.2026.03.012_bib3","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1200\/JCO.19.00934","article-title":"Five-Year Overall Survival for Patients With Advanced Non\u2012Small-Cell Lung Cancer Treated With Pembrolizumab: Results From the Phase I KEYNOTE-001 Study","volume":"37","author":"Garon","year":"2019","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.stem.2026.03.012_bib4","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1056\/NEJMoa1601202","article-title":"Ipilimumab for Patients with Relapse after Allogeneic Transplantation","volume":"375","author":"Davids","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.stem.2026.03.012_bib5","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1158\/2159-8290.CD-18-0774","article-title":"Efficacy, Safety, and Biomarkers of Response to Azacitidine and Nivolumab in Relapsed\/Refractory Acute Myeloid Leukemia: A Nonrandomized, Open-Label, Phase II Study","volume":"9","author":"Daver","year":"2019","journal-title":"Cancer Discov."},{"key":"10.1016\/j.stem.2026.03.012_bib6","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-002968","article-title":"Overexpression of CD200 is a Stem Cell-Specific Mechanism of Immune Evasion in AML","volume":"9","author":"Herbrich","year":"2021","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.stem.2026.03.012_bib7","doi-asserted-by":"crossref","first-page":"9020","DOI":"10.1073\/pnas.1818210116","article-title":"Cancer stemness, intratumoral heterogeneity, and immune response across cancers","volume":"116","author":"Miranda","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.stem.2026.03.012_bib8","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1038\/s41586-019-1410-1","article-title":"Absence of NKG2D ligands defines leukaemia stem cells and mediates their immune evasion","volume":"572","author":"Paczulla","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.stem.2026.03.012_bib9","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/s41556-022-00849-4","article-title":"VCAM1 confers innate immune tolerance on haematopoietic and leukaemic stem cells","volume":"24","author":"Pinho","year":"2022","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.stem.2026.03.012_bib10","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1038\/s41590-022-01198-y","article-title":"ILC1s control leukemia stem cell fate and limit development of AML","volume":"23","author":"Li","year":"2022","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.stem.2026.03.012_bib11","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1038\/s43018-024-00736-x","article-title":"Targeting PRMT9-mediated arginine methylation suppresses cancer stem cell maintenance and elicits cGAS-mediated anticancer immunity","volume":"5","author":"Dong","year":"2024","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.stem.2026.03.012_bib12","doi-asserted-by":"crossref","first-page":"18246","DOI":"10.1074\/jbc.270.31.18246","article-title":"The cDNA sequence of human endothelial cell multimerin. A unique protein with RGDS, coiled-coil, and epidermal growth factor-like domains and a carboxyl terminus similar to the globular domain of complement C1q and collagens type VIII and X","volume":"270","author":"Hayward","year":"1995","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.stem.2026.03.012_bib13","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1160\/TH03-02-0125","article-title":"Studies of alpha-granule proteins in cultured human megakaryocytes","volume":"90","author":"Veljkovic","year":"2003","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.stem.2026.03.012_bib14","doi-asserted-by":"crossref","first-page":"2622","DOI":"10.3390\/ijms22052622","article-title":"TNMplot.com: A Web Tool for the Comparison of Gene Expression in Normal, Tumor and Metastatic Tissues","volume":"22","author":"Bartha","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.stem.2026.03.012_bib15","doi-asserted-by":"crossref","first-page":"3187","DOI":"10.1158\/1078-0432.CCR-14-2684","article-title":"Multimerin-1 (MMRN1) as Novel Adverse Marker in Pediatric Acute Myeloid Leukemia: A Report from the Children\u2019s Oncology Group","volume":"21","author":"Laszlo","year":"2015","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.stem.2026.03.012_bib16","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1080\/15257770.2024.2335680","article-title":"Prognostic value and immunological role of MMRN1: a rising star in cancer","volume":"44","author":"Zhou","year":"2025","journal-title":"Nucleosides Nucleotides Nucleic Acids"},{"key":"10.1016\/j.stem.2026.03.012_bib17","doi-asserted-by":"crossref","first-page":"3574","DOI":"10.1158\/0008-5472.CAN-17-3376","article-title":"Sialic Acid Blockade Suppresses Tumor Growth by Enhancing T-cell-Mediated Tumor Immunity","volume":"78","author":"B\u00fcll","year":"2018","journal-title":"Cancer Res."},{"key":"10.1016\/j.stem.2026.03.012_bib18","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-021-21550-4","article-title":"Sialic acids in pancreatic cancer cells drive tumour-associated macrophage differentiation via the Siglec receptors Siglec-7 and Siglec-9","volume":"12","author":"Rodriguez","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.stem.2026.03.012_bib19","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1038\/s41589-020-0622-x","article-title":"Targeted glycan degradation potentiates the anticancer immune response in vivo","volume":"16","author":"Gray","year":"2020","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.stem.2026.03.012_bib20","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.ccell.2018.01.009","article-title":"Eradication of Triple-Negative Breast Cancer Cells by Targeting Glycosylated PD-L1","volume":"33","author":"Li","year":"2018","journal-title":"Cancer Cell"},{"key":"10.1016\/j.stem.2026.03.012_bib21","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.it.2020.02.001","article-title":"Sialoglycans and Siglecs Can Shape the Tumor Immune Microenvironment","volume":"41","author":"van de Wall","year":"2020","journal-title":"Trends Immunol."},{"key":"10.1016\/j.stem.2026.03.012_bib22","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.996746","article-title":"Siglec-7 represents a glyco-immune checkpoint for non-exhausted effector memory CD8+ T cells with high functional and metabolic capacities","volume":"13","author":"Haas","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.stem.2026.03.012_bib23","doi-asserted-by":"crossref","first-page":"43117","DOI":"10.1074\/jbc.M403538200","article-title":"Negative regulation of T cell receptor signaling by Siglec-7 (p70\/AIRM) and Siglec-9","volume":"279","author":"Ikehara","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.stem.2026.03.012_bib24","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1158\/2326-6066.CIR-18-0505","article-title":"Siglec-9 Regulates an Effector Memory CD8+ T-cell Subset That Congregates in the Melanoma Tumor Microenvironment","volume":"7","author":"Haas","year":"2019","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.stem.2026.03.012_bib25","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1016\/j.cell.2019.01.031","article-title":"Single-Cell RNA-Seq Reveals AML Hierarchies Relevant to Disease Progression and Immunity","volume":"176","author":"van Galen","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.stem.2026.03.012_bib26","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1038\/s41591-022-01819-x","article-title":"A cellular hierarchy framework for understanding heterogeneity and predicting drug response in acute myeloid leukemia","volume":"28","author":"Zeng","year":"2022","journal-title":"Nat. Med."},{"key":"10.1016\/j.stem.2026.03.012_bib27","doi-asserted-by":"crossref","first-page":"48","DOI":"10.3892\/mco.2024.2746","article-title":"MicroRNA-223 overexpression suppresses protein kinase C \u03b5 expression in human leukemia stem cell-like KG-1a cells","volume":"21","author":"Osiriphan","year":"2024","journal-title":"Mol. Clin. Oncol."},{"key":"10.1016\/j.stem.2026.03.012_bib28","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1080\/01635581.2019.1598565","article-title":"Dietary Turmeric Bisdemethoxycurcumin Suppresses Wilms\u2019 Tumor 1 and CD34 Protein Expressions in KG-1a Leukemic Stem Cells","volume":"71","author":"Panyajai","year":"2019","journal-title":"Nutr. Cancer"},{"key":"10.1016\/j.stem.2026.03.012_bib29","first-page":"1707","article-title":"Osteopontin b and c isoforms: Molecular Candidates Associated with Leukemic Stem Cell Chemoresistance in Acute Myeloid Leukemia","volume":"18","author":"Mirzaei","year":"2017","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"10.1016\/j.stem.2026.03.012_bib30","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.stem.2022.12.006","article-title":"METTL16 drives leukemogenesis and leukemia stem cell self-renewal by reprogramming BCAA metabolism","volume":"30","author":"Han","year":"2023","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.stem.2026.03.012_bib31","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.stem.2019.03.021","article-title":"Targeting the RNA m6A Reader YTHDF2 Selectively Compromises Cancer Stem Cells in Acute Myeloid Leukemia","volume":"25","author":"Paris","year":"2019","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.stem.2026.03.012_bib32","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-023-37592-9","article-title":"Oncogenic drivers dictate immune control of acute myeloid leukemia","volume":"14","author":"Austin","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.stem.2026.03.012_bib33","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1038\/nature04980","article-title":"Transformation from committed progenitor to leukaemia stem cell initiated by MLL-AF9","volume":"442","author":"Krivtsov","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.stem.2026.03.012_bib34","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1126\/science.1186624","article-title":"The Wnt\/beta-catenin pathway is required for the development of leukemia stem cells in AML","volume":"327","author":"Wang","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.stem.2026.03.012_bib35","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1159\/000356651","article-title":"KRAS (G12D) cooperates with AML1\/ETO to initiate a mouse model mimicking human acute myeloid leukemia","volume":"33","author":"Zhao","year":"2014","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.stem.2026.03.012_bib36","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms6750","article-title":"Ferrets exclusively synthesize Neu5Ac and express naturally humanized influenza A virus receptors","volume":"5","author":"Ng","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.stem.2026.03.012_bib37","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.122373","article-title":"Sialic acid catabolism by N-acetylneuraminate pyruvate lyase is essential for muscle function","volume":"3","author":"Wen","year":"2018","journal-title":"JCI Insight"},{"key":"10.1016\/j.stem.2026.03.012_bib38","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1038\/nri3737","article-title":"Siglec-mediated regulation of immune cell function in disease","volume":"14","author":"Macauley","year":"2014","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.stem.2026.03.012_bib39","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/nchembio.999","article-title":"Global metabolic inhibitors of sialyl- and fucosyltransferases remodel the glycome","volume":"8","author":"Rillahan","year":"2012","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.stem.2026.03.012_bib40","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1038\/s41423-020-0365-3","article-title":"Enforced PGC-1\u03b1 expression promotes CD8 T cell fitness, memory formation and antitumor immunity","volume":"18","author":"Dumauthioz","year":"2021","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.stem.2026.03.012_bib41","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/s12943-020-01238-x","article-title":"Natural killer cells in cancer biology and therapy","volume":"19","author":"Wu","year":"2020","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.stem.2026.03.012_bib42","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.trecan.2023.11.009","article-title":"Targeting myeloid cells for cancer immunotherapy: Siglec-7\/9\/10\/15 and their ligands","volume":"10","author":"Boelaars","year":"2024","journal-title":"Trends Cancer"},{"key":"10.1016\/j.stem.2026.03.012_bib43","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adh4379","article-title":"Siglec-7 glyco-immune binding mAbs or NK cell engager biologics induce potent antitumor immunity against ovarian cancers","volume":"9","author":"Bordoloi","year":"2023","journal-title":"Sci. Adv."},{"key":"10.1016\/j.stem.2026.03.012_bib44","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.canlet.2016.10.009","article-title":"EGFL7 is an intercellular EGFR signal messenger that plays an oncogenic role in glioma","volume":"384","author":"Wang","year":"2017","journal-title":"Cancer Lett."},{"key":"10.1016\/j.stem.2026.03.012_bib45","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1002\/psc.450","article-title":"The chemical synthesis and binding affinity to the EGF receptor of the EGF-like domain of heparin-binding EGF-like growth factor (HB-EGF)","volume":"9","author":"Shin","year":"2003","journal-title":"J. Pept. Sci."},{"key":"10.1016\/j.stem.2026.03.012_bib46","article-title":"Fibulin7 Mediated Pathological Cardiac Remodeling through EGFR Binding and EGFR-Dependent FAK\/AKT Signaling Activation","volume":"10","author":"Zheng","year":"2023","journal-title":"Adv. Sci. (Weinh)"},{"key":"10.1016\/j.stem.2026.03.012_bib47","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/0092-8674(91)90410-Z","article-title":"Cloning of PI3 kinase-associated p85 utilizing a novel method for expression\/cloning of target proteins for receptor tyrosine kinases","volume":"65","author":"Skolnik","year":"1991","journal-title":"Cell"},{"key":"10.1016\/j.stem.2026.03.012_bib48","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.3892\/or.2014.3102","article-title":"Transphosphorylation of EGFR at Y845 plays an important role in its autophosphorylation and kinase activity","volume":"31","author":"Song","year":"2014","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.stem.2026.03.012_bib49","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.apsb.2015.07.001","article-title":"Mechanisms of resistance to EGFR tyrosine kinase inhibitors","volume":"5","author":"Huang","year":"2015","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.stem.2026.03.012_bib50","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.ccell.2020.05.014","article-title":"Targeting RSPO3-LGR4 Signaling for Leukemia Stem Cell Eradication in Acute Myeloid Leukemia","volume":"38","author":"Salik","year":"2020","journal-title":"Cancer Cell"},{"key":"10.1016\/j.stem.2026.03.012_bib51","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/s13287-021-02155-6","article-title":"CD9, a potential leukemia stem cell marker, regulates drug resistance and leukemia development in acute myeloid leukemia","volume":"12","author":"Liu","year":"2021","journal-title":"Stem Cell Res. Ther."},{"key":"10.1016\/j.stem.2026.03.012_bib52","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1182\/blood.2021010980","article-title":"A STAT5B-CD9 axis determines self-renewal in hematopoietic and leukemic stem cells","volume":"138","author":"Kollmann","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.stem.2026.03.012_bib53","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1182\/blood.2019001982","article-title":"How I treat relapsed or refractory AML","volume":"136","author":"DeWolf","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.stem.2026.03.012_bib54","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1182\/blood.2022018246","article-title":"Mechanisms of response and resistance to combined decitabine and ipilimumab for advanced myeloid disease","volume":"141","author":"Penter","year":"2023","journal-title":"Blood"},{"key":"10.1016\/j.stem.2026.03.012_bib55","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/s13046-021-01904-y","article-title":"Elafin promotes tumour metastasis and attenuates the anti-metastatic effects of erlotinib via binding to EGFR in hepatocellular carcinoma","volume":"40","author":"Wang","year":"2021","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.stem.2026.03.012_bib56","doi-asserted-by":"crossref","first-page":"3845","DOI":"10.1158\/0008-5472.CAN-21-4140","article-title":"Inhibition of EGFR Overcomes Acquired Lenvatinib Resistance Driven by STAT3-ABCB1 Signaling in Hepatocellular Carcinoma","volume":"82","author":"Hu","year":"2022","journal-title":"Cancer Res."},{"key":"10.1016\/j.stem.2026.03.012_bib57","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.7150\/thno.23177","article-title":"Overcoming erlotinib resistance in EGFR mutation-positive lung adenocarcinomas through repression of phosphoglycerate dehydrogenase","volume":"8","author":"Dong","year":"2018","journal-title":"Theranostics"},{"key":"10.1016\/j.stem.2026.03.012_bib58","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1182\/blood-2007-01-069856","article-title":"Complete remission in a patient with acute myelogenous leukemia treated with erlotinib for non small-cell lung cancer","volume":"110","author":"Chan","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.stem.2026.03.012_bib59","doi-asserted-by":"crossref","first-page":"3645","DOI":"10.1200\/JCO.2008.17.0357","article-title":"Erlotinib in a patient with acute myelogenous leukemia and concomitant non-small-cell lung cancer","volume":"26","author":"Pitini","year":"2008","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.stem.2026.03.012_bib60","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1158\/2159-8290.CD-20-1375","article-title":"Chemotherapy Induces Senescence-Like Resilient Cells Capable of Initiating AML Recurrence","volume":"11","author":"Duy","year":"2021","journal-title":"Cancer Discov."},{"key":"10.1016\/j.stem.2026.03.012_bib61","doi-asserted-by":"crossref","DOI":"10.1080\/16078454.2024.2439054","article-title":"Effect of hypomethylating agents on prognosis in acute myeloid leukemia patients treated with HAG priming: a systematic review and meta-analysis","volume":"29","author":"Li","year":"2024","journal-title":"Hematology"},{"key":"10.1016\/j.stem.2026.03.012_bib62","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.adf4299","article-title":"EGFR-dependent endocytosis of Wnt9a and Fzd9b promotes \u03b2-catenin signaling during hematopoietic stem cell development in zebrafish","volume":"17","author":"Nguyen","year":"2024","journal-title":"Sci. Signal."},{"key":"10.1016\/j.stem.2026.03.012_bib63","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1038\/s41556-019-0330-5","article-title":"EGFR is required for Wnt9a-Fzd9b signalling specificity in haematopoietic stem cells","volume":"21","author":"Grainger","year":"2019","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.stem.2026.03.012_bib64","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2024.110306","article-title":"Epidermal growth factor augments the self-renewal capacity of aged hematopoietic stem cells","volume":"27","author":"Chang","year":"2024","journal-title":"iScience"},{"key":"10.1016\/j.stem.2026.03.012_bib65","doi-asserted-by":"crossref","first-page":"10761","DOI":"10.3390\/ijms140610761","article-title":"Cellular functions regulated by phosphorylation of EGFR on Tyr845","volume":"14","author":"Sato","year":"2013","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.stem.2026.03.012_bib66","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1016\/j.cmet.2022.07.005","article-title":"CD24-Siglec axis is an innate immune checkpoint against metaflammation and metabolic disorder","volume":"34","author":"Wang","year":"2022","journal-title":"Cell Metab."},{"key":"10.1016\/j.stem.2026.03.012_bib67","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/nri2056","article-title":"Siglecs and their roles in the immune system","volume":"7","author":"Crocker","year":"2007","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.stem.2026.03.012_bib68","doi-asserted-by":"crossref","DOI":"10.1172\/JCI180282","article-title":"Sialylated glycoproteins suppress immune cell killing by binding to Siglec-7 and Siglec-9 in prostate cancer","volume":"134","author":"Wen","year":"2024","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.stem.2026.03.012_bib69","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2215376120","article-title":"MYC-driven synthesis of Siglec ligands is a glycoimmune checkpoint","volume":"120","author":"Smith","year":"2023","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.stem.2026.03.012_bib70","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aab3459","article-title":"Targeting Siglecs with a sialic acid-decorated nanoparticle abrogates inflammation","volume":"7","author":"Spence","year":"2015","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.stem.2026.03.012_bib71","doi-asserted-by":"crossref","first-page":"2841","DOI":"10.1182\/blood-2005-02-0488","article-title":"Gefitinib induces myeloid differentiation of acute myeloid leukemia","volume":"106","author":"Stegmaier","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.stem.2026.03.012_bib72","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/s13045-016-0294-x","article-title":"Epidermal growth factor receptor is expressed and active in a subset of acute myeloid leukemia","volume":"9","author":"Mahmud","year":"2016","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.stem.2026.03.012_bib73","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1159\/000355185","article-title":"Expression of epidermal growth factor receptor by an experimental murine tumor of acute myeloid leukemia origin","volume":"131","author":"Ben-Ishay","year":"2014","journal-title":"Acta Haematol."},{"key":"10.1016\/j.stem.2026.03.012_bib74","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1002\/hon.1002","article-title":"Epidermal growth factor receptor expression in acute myelogenous leukaemia is associated with clinical prognosis","volume":"30","author":"Sun","year":"2012","journal-title":"Hematol. Oncol."},{"key":"10.1016\/j.stem.2026.03.012_bib75","doi-asserted-by":"crossref","first-page":"3008","DOI":"10.3390\/biomedicines10123008","article-title":"Molecular-Targeted Therapy for Tumor-Agnostic Mutations in Acute Myeloid Leukemia","volume":"10","author":"Arai","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.stem.2026.03.012_bib76","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.1182\/blood-2007-07-100362","article-title":"Erlotinib exhibits antineoplastic off-target effects in AML and MDS: a preclinical study","volume":"111","author":"Boehrer","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.stem.2026.03.012_bib77","doi-asserted-by":"crossref","first-page":"10182","DOI":"10.1096\/fj.201902922RR","article-title":"Erlotinib is effective against FLT3-ITD mutant AML and helps to overcome intratumoral heterogeneity via targeting FLT3 and Lyn","volume":"34","author":"Cao","year":"2020","journal-title":"FASEB J."},{"key":"10.1016\/j.stem.2026.03.012_bib78","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1016\/j.leukres.2014.09.014","article-title":"A phase I\/II trial of Erlotinib in higher risk myelodysplastic syndromes and acute myeloid leukemia after azacitidine failure","volume":"38","author":"Thepot","year":"2014","journal-title":"Leuk. Res."},{"key":"10.1016\/j.stem.2026.03.012_bib79","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1016\/j.bcp.2011.05.011","article-title":"Tyrosine kinase inhibitors for the treatment of acute myeloid leukemia: delineation of anti-leukemic mechanisms of action","volume":"82","author":"Lainey","year":"2011","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.stem.2026.03.012_bib80","doi-asserted-by":"crossref","first-page":"4079","DOI":"10.4161\/cc.22382","article-title":"Erlotinib antagonizes ABC transporters in acute myeloid leukemia","volume":"11","author":"Lainey","year":"2012","journal-title":"Cell Cycle (Georget. Tex.)"},{"key":"10.1016\/j.stem.2026.03.012_bib81","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1016\/j.bcp.2008.05.024","article-title":"Erlotinib and gefitinib for the treatment of myelodysplastic syndrome and acute myeloid leukemia: a preclinical comparison","volume":"76","author":"Boehrer","year":"2008","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.stem.2026.03.012_bib82","doi-asserted-by":"crossref","first-page":"4331","DOI":"10.1038\/onc.2012.469","article-title":"Azacytidine and erlotinib exert synergistic effects against acute myeloid leukemia","volume":"32","author":"Lainey","year":"2013","journal-title":"Oncogene"},{"key":"10.1016\/j.stem.2026.03.012_bib83","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1002\/ajh.23749","article-title":"Phase II clinical study of erlotinib for treatment of myelodysplastic syndromes","volume":"89","author":"Komrokji","year":"2014","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.stem.2026.03.012_bib84","doi-asserted-by":"crossref","first-page":"3168","DOI":"10.4161\/cc.10.18.16599","article-title":"Erlotinib antagonizes constitutive activation of SRC family kinases and mTOR in acute myeloid leukemia","volume":"10","author":"Boehrer","year":"2011","journal-title":"Cell Cycle (Georget. Tex.)"},{"key":"10.1016\/j.stem.2026.03.012_bib85","doi-asserted-by":"crossref","first-page":"2978","DOI":"10.4161\/cc.26016","article-title":"EGFR inhibitors exacerbate differentiation and cell cycle arrest induced by retinoic acid and vitamin D3 in acute myeloid leukemia cells","volume":"12","author":"Lainey","year":"2013","journal-title":"Cell Cycle (Georget. Tex.)"},{"key":"10.1016\/j.stem.2026.03.012_bib86","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1159\/000490092","article-title":"A Pilot Phase II Study of Erlotinib for the Treatment of Patients with Relapsed\/Refractory Acute Myeloid Leukemia","volume":"140","author":"Abou Dalle","year":"2018","journal-title":"Acta Haematol."},{"key":"10.1016\/j.stem.2026.03.012_bib87","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.leukres.2014.11.022","article-title":"Pilot study of erlotinib in patients with acute myeloid leukemia","volume":"39","author":"Sayar","year":"2015","journal-title":"Leuk. Res."},{"key":"10.1016\/j.stem.2026.03.012_bib88","doi-asserted-by":"crossref","DOI":"10.1002\/jev2.12168","article-title":"Tumour-derived small extracellular vesicles suppress CD8+ T cell immune function by inhibiting SLC6A8-mediated creatine import in NPM1-mutated acute myeloid leukaemia","volume":"10","author":"Peng","year":"2021","journal-title":"J. Extracell. Vesicles"},{"key":"10.1016\/j.stem.2026.03.012_bib89","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1158\/2326-6066.CIR-17-0550","article-title":"CD16A Activation of NK Cells Promotes NK Cell Proliferation and Memory-Like Cytotoxicity against Cancer Cells","volume":"6","author":"Pahl","year":"2018","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.stem.2026.03.012_bib90","article-title":"Targeting USP10\u2013FAK pathway sensitizes BCR-ABL+ leukemia cells to tyrosine kinase inhibitors","volume":"1","author":"Qiu","year":"2025","journal-title":"Cell Investig."},{"key":"10.1016\/j.stem.2026.03.012_bib91","article-title":"TRIM24 drives colorectal cancer progression via CAVIN2 degradation and ERK\/RhoA pathway activation","volume":"1","author":"Cai","year":"2025","journal-title":"Cell Investig."},{"key":"10.1016\/j.stem.2026.03.012_bib92","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.1038\/s41375-024-02423-3","article-title":"Essential role of Dhx16-mediated ribosome assembly in maintenance of hematopoietic stem cells","volume":"38","author":"Li","year":"2024","journal-title":"Leukemia"},{"key":"10.1016\/j.stem.2026.03.012_bib93","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/s41586-018-0615-z","article-title":"LILRB4 signalling in leukaemia cells mediates T cell suppression and tumour infiltration","volume":"562","author":"Deng","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.stem.2026.03.012_bib94","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1038\/s41375-019-0639-x","article-title":"RIG-I-based immunotherapy enhances survival in preclinical AML models and sensitizes AML cells to checkpoint blockade","volume":"34","author":"Ruzicka","year":"2020","journal-title":"Leukemia"},{"key":"10.1016\/j.stem.2026.03.012_bib95","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1016\/j.ccell.2023.09.010","article-title":"Cooperative CAR targeting to selectively eliminate AML and minimize escape","volume":"41","author":"Haubner","year":"2023","journal-title":"Cancer Cell"}],"container-title":["Cell Stem Cell"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1934590926001220?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1934590926001220?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T01:05:43Z","timestamp":1783127143000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1934590926001220"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":95,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S1934590926001220"],"URL":"https:\/\/doi.org\/10.1016\/j.stem.2026.03.012","relation":{},"ISSN":["1934-5909"],"issn-type":[{"value":"1934-5909","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"MMRN1-EGFR drives sialylglycan-Siglec immune evasion in AML leukemia stem cells","name":"articletitle","label":"Article Title"},{"value":"Cell Stem Cell","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.stem.2026.03.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}